Paget's Disease: Diagnosis, Management, and Insights into the Breast (PDB)
Paget's disease of the breast is found more often in countries like the United States and those in Western Europe, compared to places in Asia. This could be because people in those countries have more access to doctors, tests, and information about breast health. Even though this disease is not very common, it's important to pay attention to it because it can be connected to other serious breast tumors. Catching and treating it early helps people have better results and stay healthier in the long run.
Table of Contents:
Paget's disease of the breast is a rare breast cancer that affects the skin of the nipple and sometimes the areola. It is characterized by a rash or eczema like appearance on the nipple and areola which can be accompanied by itching, redness and discharge. It is often associated with an underlying breast cancer which can be invasive or non-invasive (ductal carcinoma in situ, DCIS). Paget's disease of the breast is named after Sir James Paget, a 19th century British doctor who first described the condition.
The pathogenesis of PDB is explained by two theories:
The first theory is the epidermotropic theory which suggests that Paget cells come from an underlying ductal carcinoma in situ (DCIS) or invasive breast carcinoma. These cells retain their malignant properties and contribute to the histopathological findings of Paget's disease. These cancer cells are thought to migrate from an underlying carcinoma through the lactiferous ducts to the nipple epidermis.
The second theory is the in situ transformation theory which suggests that Paget cells arise as a primary intraepidermal malignancy independent of any underlying breast carcinoma. This theory is supported by cases where no underlying breast tumor is found.
Epidermotropic Theory: This is the most widely accepted theory which suggests that malignant ductal cells migrate from an underlying carcinoma through the lactiferous ducts to the epidermis of the nipple. These cells retain their malignant properties and contribute to the histopathological findings of Paget's disease. This theory is supported by the frequent finding of underlying DCIS or invasive carcinoma in patients with PDB. In some cases this underlying carcinoma can be an invasive breast cancer which affects the prognosis and treatment.
In Situ Transformation Theory: This is an alternative theory which suggests that malignant cells arise de novo within the epidermis of the nipple possibly due to local field effects or genetic mutations. Although this theory is less accepted, it highlights the complexity of the disease. Further research is needed to understand the molecular mechanisms.
Characteristic features are large, pale, vacuolated Paget cells in the epidermis often with HER2 overexpression. The strong association with DCIS or invasive carcinoma emphasizes the need for full evaluation. [2] Recent studies have looked at molecular pathways including HER2 signaling and immune evasion mechanisms as potential targets for treatment. For example HER2 targeted therapy like trastuzumab has shown promise in improving outcomes.
Paget's disease of the breast is a rare condition and accounts for about 1-4% of all breast cancer. The exact cause of Paget's disease is not known but it is associated with underlying breast cancer. The risk factors for Paget's disease are similar to breast cancer:
Knowing these risk factors is important for early detection and prevention. Regular screenings and genetic counseling can help identify those at higher risk and can be managed proactively. [4]
PDB usually presents with changes in the nipple-areola complex:
Unilateral symptoms are common but bilateral symptoms are rare and should prompt consideration of other diagnoses. Symptom progression varies; early cases may present with subtle scaling and advanced cases may have ulceration and nipple destruction. Recognizing these stages is important for timely interventions. Case studies show that early detection of these subtle signs can improve prognosis.
Diagnosis of PDB is a combination of clinical evaluation, imaging and histopathological assessment. If an underlying cancer is suspected, a sentinel lymph node biopsy may be done to assess the spread of cancer to the axillary lymph nodes. [5]
A comparison of imaging modalities shows that MRI is more sensitive than mammography and ultrasound especially in younger patients or those with dense breasts. However, the cost and false positive results should be considered. Advanced techniques like diffusion-weighted imaging (DWI) and contrast-enhanced mammography are emerging as promising tools to improve diagnostic accuracy.
Immunohistochemistry: HER2 is overexpressed in 80-100% of cases, ER and PR status varies depending on the underlying cancer. Advances in molecular diagnostics including next-generation sequencing is helping us understand the genetic basis of PDB. For example, TP53 and PIK3CA mutations have been linked to disease progression and potential targets for therapy.
Treatment of PDB depends on the extent of disease and presence of underlying cancer. Treatment options are surgery, radiation and systemic therapy.
Radiation Therapy: Reduces local recurrence, especially after BCS. Whole breast radiation therapy is usually recommended after BCS to make sure any remaining cancer cells are killed and reduce the risk of recurrence.
Oncoplastic surgery has improved the cosmetic outcome for BCS patients. Nipple-sparing mastectomy is also becoming popular, balancing oncological safety and aesthetic preservation. 3D imaging and intraoperative margin assessment has further improved surgical precision.
Emerging therapies like antibody-drug conjugates (e.g. trastuzumab deruxtecan) and immune checkpoint inhibitors are being studied in clinical trials and may add to the treatment options for PDB. Combination therapy targeting both HER2 and PD-1/PD-L1 are showing promising results in early phase trials and may be the future of personalized medicine.
Prognosis of Paget's disease of the breast depends on the underlying cancer and stage of the disease. If the underlying cancer is non-invasive (DCIS), prognosis is good, 5 year survival is over 90%. If the underlying cancer is invasive, prognosis is poor, 5 year survival is 50-60%. Prognosis is poorer if the cancer has spread to the nodes or other parts of the body.
Early detection and comprehensive treatment is key to better outcomes. Advances in imaging and targeted therapy has improved the management of Paget's disease and hope for better survival and quality of life.
In peripartum women presenting with nipple-areola complex changes, PDB should be included in the differential diagnosis. PDB is often associated with tumors in the same breast tissue so it is important to evaluate the same breast for any underlying tumors. Diagnostic delays are common because PDB looks like benign conditions.
Multidisciplinary management is important to balance maternal and fetal well being while ensuring prompt treatment [2]. Case reports have shown the challenges of managing PDB during pregnancy and the importance of individualized care plan. Imaging modalities like ultrasound which is non-ionizing radiation is preferred during pregnancy.
Modern Treatment TrendsBreast conserving approach is the trend now with improvements in imaging, surgery and adjuvant therapy. Personalized treatment plan based on tumor biology and patient preference has resulted to better functional and cosmetic outcome. AI is also being integrated in imaging and pathology to aid in earlier detection and more accurate diagnosis of PDB.
Patient education and awareness is key in the diagnosis and treatment of Paget's disease of the breast. Women should be aware of the signs and symptoms of Paget's disease, a rash or eczema like appearance on the nipple and areola, itching, redness and discharge. Women should also be aware of their risk for breast cancer and take steps to reduce their risk, get regular mammograms and do breast self exam.
Educational campaigns and resources can help women to seek medical attention if they notice any changes in their breast tissue. Early intervention can make a big difference in prognosis and treatment outcome.
Multidisciplinary approach is important in the diagnosis and treatment of Paget's disease of the breast. A team of healthcare professionals including breast surgeon, medical oncologist, radiation oncologist and pathologist should work together to develop a treatment plan that is individualized to the patient. Treatment may include surgery, radiation therapy, chemotherapy and hormone therapy depending on the underlying cancer and stage of the disease.
Team work among specialists ensures comprehensive care of all aspects of the disease. This team based approach not only improves clinical outcome but also the overall well being of the patient and provide holistic treatment experience.
Paget's disease of the breast is a rare but significant malignancy that requires high index of suspicion for early diagnosis. Mammary Paget disease which involves the nipple-areola complex requires thorough understanding of its clinical presentation and underlying pathology.
Advances in imaging, histopathology and systemic therapy has improved diagnostic accuracy and treatment outcome. Breast conserving surgery when possible is a trend towards less invasive management which is patient centered.
Future research should focus on the molecular mechanism of PDB and identification of new therapeutic targets to further improve outcome. Development of AI driven diagnostic tool and precision therapy will be the game changer in PDB management in the coming years.
[1] Hudson-Phillips, S., Cox, K., Patel, P., & Al Sarakbi, W. (2023). Paget's disease of the breast: diagnosis and management. British journal of hospital medicine (London, England : 2005), 84(1), 1–8. https://doi.org/10.12968/hmed.2022.0439
[2] Gilmore, R., Prasath, V., & Habibi, M. (2020). Paget Disease of the Breast in Pregnancy and Lactation. Advances in experimental medicine and biology, 1252, 133–136. https://doi.org/10.1007/978-3-030-41596-9_18
[3] Karakas C. (2011). Paget's disease of the breast. Journal of carcinogenesis, 10, 31. https://doi.org/10.4103/1477-3163.90676
[4] Dalton, J. C., & Plichta, J. K. (2024). Paget's disease of the breast: Insights from imaging to guide surgical management. American journal of surgery, 231, 16–17. https://doi.org/10.1016/j.amjsurg.2024.03.013
[5] Sakorafas, G. H., Blanchard, K., Sarr, M. G., & Farley, D. R. (2001). Paget's disease of the breast. Cancer treatment reviews, 27(1), 9–18. https://doi.org/10.1053/ctrv.2000.0203
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
7 hours ago
- Yahoo
Your Meal Deal Might Be Raising Your Risk Of Lung Cancer, Study Warns
Eating ultra-processed food (UPFs) has already been linked to 32 harmful effects to health, including a raised risk of type 2 diabetes, heart disease and early death. Now, another study has linked a higher intake of ultra-processed food to an increased risk of lung cancer. Lung cancer is the most common cancer in the world. It's the third most common cancer in the UK, with around 49,000 people diagnosed each year. Previous research has noted a 'significant association' between intake of UPF and the risk of several cancers, including colorectal, breast and pancreatic cancer. Here's what you need to know about the latest study. First up, what is ultra-processed food? Ultra-processed food typically undergoes multiple processing steps and contains long lists of additives and preservatives. It's often ready-to-eat or heat. Examples include ham, mass-produced bread, cereal, crisps and biscuits. It's thought more than half of the typical British daily diet is made up of ultra-processed food. But not all of these foods are terrible news – yoghurt and high-fibre cereals, for instance, can form a part of a healthy diet. There is however a clear link emerging between negative health outcomes and diets high in UPF. The Food Standards Agency (FSA) noted 'we still don't know whether it is because these foods are unhealthy because of how they are made, or if it's because a large majority of processed foods are high in calories, saturated fat, salt and sugar'. UPF intake also increases the risk of weight gain, overweight and obesity, which is the second biggest cause of cancer in the UK. As high consumption has already been linked to a heightened risk of several health conditions, researchers wanted to know if this might also include lung cancer. What did the new lung cancer study find? Researchers used data from the US Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trials, involving 155,000 participants aged 55–74. Cancer diagnoses were tracked until the end of 2009 and cancer deaths until the end of 2018. Some 101,732 people (50,187 men and 51,545 women; average age 62) who completed a Food Frequency questionnaire on their dietary habits on entry to the trials were included in the study. Foods were categorised as: unprocessed or minimally-processed; containing processed culinary ingredients; processed; and ultra-processed. The three types of UPF that featured the most were lunch meat (11%), diet or caffeinated soft drinks (just over 7%) and decaffeinated soft drinks (nearly 7%). Over a period of 12 years, 1,706 new cases of lung cancer were diagnosed, including 1,473 (86%) cases of non-small cell lung cancer and 233 (14%) of small cell lung cancer. After accounting for factors including smoking and overall diet quality, researchers discovered participants who ate a diet high in UPF were 41% more likely to be diagnosed with lung cancer than those who ate the least UPF. Specifically, they were 37% more likely to be diagnosed with non-small cell lung cancer and 44% more likely to be diagnosed with small cell lung cancer. The findings were shared in the respiratory journal, Thorax. The study has major limitations The study is observational, so no firm conclusions can be drawn about cause and effect. The researchers also acknowledged they weren't able to factor in smoking intensity (worth noting given smoking is the main cause of lung cancer) and dietary information was collected once, so couldn't account for changes over time. In response to the study, Professor Sam Hare, consultant chest radiologist at the Royal Free London NHS Trust, said: 'A quarter of lung cancer cases occur in non-smokers so we do need research exploring whether other factors are associated with lung cancer. We also know immunity is linked to cancer biology so it is a good idea to do research into factors like diet.' Yet he said more work is needed to establish direct causation between UPFs and lung cancer. 'Crucially, whilst the study does make some adjustments for smoking status, the amount of smoking is not factored in, which is known to be directly related to lung cancer development,' he said. 'Dietary habits also change considerably over the course of such long term studies. As such, it is difficult to directly conclude that lung cancer is related to the level of UPF consumption alone given it was only declared at the start of the study.' Professor Tom Sanders, an expert in nutrition at King's College London, also noted the smoking link, and added: 'Unhealthy diets often go hand in hand with smoking habit and low socioeconomic status. But there appears to be no plausible mechanism to explain why ultra-processed food should affect risk of lung cancer.' Should you cut out UPFs? The study's researchers suggested limiting consumption of ultra-processed food may help curb the global toll of lung cancer. Supermarkets are home to thousands of UPF products, which can make it really hard to know where to turn during your weekly food shop. Often, these are the most affordable products, too. The British Heart Foundation previously advised: 'Instead of trying to completely cut out these foods, think about the balance in your diet. 'Make sure that there are minimally processed foods in there too – eat fruit and vegetables with your meals and drink water instead of sugary drinks – and try to fit in time over the week for home cooking.' Whole grains, fruit, and vegetables could help protect against cancer, so it's certainly worth trying to add more of these to your trolley if you can. Related... The 1 Processed Food That Is Actually Really Good For You, According To An Expert These Are The Ultra-Processed Foods Linked To Depression, Anxiety And 30 Other Conditions 'Ultra-Processed' Foods Are Linked To Cognitive Decline – And You're Probably Eating Them
Miami Herald
9 hours ago
- Miami Herald
David Nabarro, doctor who tried to raise millions to treat cholera in Haiti, dies at 75
The United Nations and world health community are mourning the death of David Nabarro, the British physician and public health champion who led the U.N response to eradicating cholera in Haiti after taking on some of the world's most pressing diseases, including Ebola. A passionate advocate who was once described to the Miami Herald as the U.N.'s go-to guy for responding 'to really tricky' situations, Nabarro died Friday at his home in Ferney-Voltaire, France, a suburb of Geneva, according to the 4SD Foundation, a Switzerland-based social enterprise he founded and where he served as strategic director. He was 75. His passing was described as a 'sudden death.' 'Dr. Nabarro was a tireless advocate for global health -- a leader who brought clarity, compassion and conviction to some of the world's most complex health emergencies, from AIDS and malaria to avian influenza and the COVID-19 pandemic,' Farhan Haq, deputy spokesperson for U.N. Secretary-General António Guterres, said in a statement Tuesday. 'He dedicated his life to the conviction that health is a human right — and worked to help make that right a reality for all people everywhere,' Haq added. Nabarro was known for his organized, results-oriented style and willingness to take personal risks. During the COVID pandemic, he served as one of six special envoys to the World Health Organization dealing with the coronavirus crisis. For his efforts and overall contributions to global health, he was knighted by King Charles III in 2023. Among those contributions was his fight against Ebola. With more than 30 years experience as a public health doctor when he was appointed coordinator of the U.N's efforts, Nabarro ended up raising $3.5 billion to fight Ebola despite the incessant and worrying questions from donors asking him if he knew what he was doing and if he had a strategy. 'There was a question mark always over whether or not we had a strategy that made sense, whether or not we knew what we were up to,'' he told the Herald in a 2016 interview. Soon he faced the same kinds of question as he tried to raise $400 million for the U.N.'s cholera plan in Haiti. Nabarro had been tapped to serve as special adviser to then Secretary-General Ban Ki-moon, who after years of fighting litigation efforts by victims and refusing to acknowledge the U.N.'s role in inadvertently introducing the deadly disease into Haiti, was ready to take it on the problem. Scientific studies and a confidential U.N. report had traced Haiti's outbreak to Nepalese soldiers, part of a U.N. peacekeeping contingent stationed near a river in the rural town of Mirebalais after the devastating Jan. 12, 2010, earthquake. By the time Nabarro was involved cholera had killed at least 9,393 people and sickened more than 790,840 in the Caribbean country. His job was to help the secretary general raise hundreds of millions of dollars over two years to fund a U.N. plan to eliminate cholera with rapid responses, vaccinations and improving long-term access to clean water and sanitation. By the time Nabarro came on the scene in late 2016, Ban had finally admitted the U.N.'s role and offered an apology during a meeting of the U.N. General Assembly. He wanted Nabarro to do for cholera what he had done for Ebola in Africa: galvanize government efforts and raise money. 'I have no illusions about this. It's going to be tough,' Nabarro told the Herald two weeks before visiting Haiti with Ban. 'But I am not scared by it.' Over the next few months, Nabarro made other visits and devoted himself to the cholera problem as well as to the fight against global hunger. To understand the waterborne disease's evolution and response, he reached out to a number of public health experts including Ariel Henry. The physician, who would later serve as Haiti's prime minister, was in the administration of then-President René Préval and was helping with the government's response. At the time Préval was facing immense pressure from the Obama administration to hold presidential and legislative elections in Haiti despite the deaths of more than 300,000 people and 1.5 million homeless in the quake. Fearing that placing blame on the U.N. would lead to the departure of its blue helmet peacekeepers and open the door to more violence and instability, Préval tried to manage the response on his own. But as time went by, pressure built for the U.N. to not only acknowledge its role but to apologize and compensate victims. Instead of checks to victims, Ban called for vaccinating adults and dispatching more rapid response teams within 24 to 48 hours of an infection. He also pledged that the U.N. would improve water and sanitation in places where cholera had spread. In an email exchange in 2017 while vying for the top job at the World Health Organization, Nabarro acknowledged that the effort to raise financing to eradicate cholera in Haiti had not been easy. The amount of money raised was small, but he still held onto hope that the benefits would be enormous. 'I really do hope that I get to the director general of the World Health Organization as I would then be able to give a very high priority to a concerted and sustained effort to reduce the incidence of cholera in the country and to help all Haitians to access drinking water and functioning sanitation,' he told a Herald reporter. Nabarro lost out on the WHO job to Tedros Adhanom Ghebreyesus. In a post on the social media platform X on Saturday, Ghebreyesus remembered Nabarro as 'a great champion of global health and health equity, and a wise, generous mentor to countless individuals.' Through Nabarro's efforts and those of others in Haiti, the country was declared cholera-free in February 2022 by Henry, now the country's prime minister, after three years without a confirmed case. The celebration was short-lived. By the end of the year, repeated gang clashes, which cut off access to water, fuel and hospitals in Port-au-Prince, gave rise to a resurgence of cholera cases. Nabarro is survived by his wife, Flo; his children, Tom, Ollie, Polly, Josie and Lucas, and seven grandchildren.
Newsweek
19 hours ago
- Newsweek
Donald Trump's Hands Under Scrutiny in New Photos
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. New photos of President Donald Trump's hands have led to renewed scrutiny about his health. Posting on social media, users have shared images of Trump during his visit to Europe, saying his hands are "swollen and bruised." Others suggested he was wearing makeup to conceal bruises. Why It Matters Earlier this month, the White House announced that Trump, who became the oldest person sworn in as president at the beginning of his second term, had been diagnosed with chronic venous insufficiency (CVI), something his doctor described as "benign and common." CVI is a condition in which the veins in the legs are unable to efficiently return blood to the heart. It is not life-threatening. The White House's announcement came after photos of Trump at various events showed swelling in his legs and bruises on his hands, which sparked public scrutiny about his health and fitness. Some have called for the 79-year-old to release his full medical records. President Donald Trump clasps his hands as he speaks with the media during a meeting with British Prime Minister Keir Starmer at the Trump Turnberry golf course in Scotland on July 28. President Donald Trump clasps his hands as he speaks with the media during a meeting with British Prime Minister Keir Starmer at the Trump Turnberry golf course in Scotland on July 28. AP Photo/Jacquelyn Martin What To Know X users weighed in on photos taken of Trump's hands during his recent trip to Scotland, where he met EU leaders. One user posted a video of the president's hands, saying Trump's signs of CVI had been "reportedly covered with makeup." Democratic activist Chris D. Jackson posted an image and added: "Wow. Look at those swollen and bruised hands in this photo from yesterday. Trump is not well." Another user replied, "So bad they're putting makeup on them." Age was a key theme of debate in last year's presidential election, with Trump often criticizing his opponent, then-President Joe Biden, as being too old to lead. Amid the increased scrutiny over Trump's fitness, White House press secretary Karoline Leavitt said, "The president remains in excellent health." At a news briefing, she said the president's medical team found "no evidence of deep vein thrombosis or arterial disease" and that he was not experiencing any discomfort related to CVI. Leavitt added that the bruise on his hand was consistent with irritation from "frequent handshaking and the use of aspirin." What People Are Saying Sean Barbabella, the president's physician, wrote in a memo: "The president underwent a comprehensive examination, including diagnostic vascular studies. Bilateral lower extremity venous Doppler ultrasounds were performed and revealed chronic venous insufficiency, a benign and common condition, particularly in individuals over the age of 70." Dr. Brian Funaki, a leading expert in vascular and interventional radiology at the University of Chicago Medicine, previously told Newsweek: "Generally speaking it is not life-threatening in and of itself, but it can predispose to developing blood clots in the veins in the legs—which, in the worst-case scenario, could break off and migrate to the lungs, causing pulmonary emboli, which can be fatal. This is why some people with this condition are treated with anticoagulation or other means, such as an inferior vena cava filter, which is a device designed to catch migrating blood clots." What Happens Next Though Trump's medical team has said he is in good health, scrutiny over his health is likely to continue.
